Napoli Shkolnik Represents Portland, ME in Opioid Epidemic

NJ Law Journal Quotes Hunter About Diabetes Drug Lawsuit

May 5, 2017

In April 2016 the U.S. Food and Drug Administration (FDA) announced the need for stronger heart problem warnings on the diabetes drug saxagliptin, sold under the names Onglyza  and Kombigleze XR. A 2015  internal study conducted by the pharmaceutical companies themselves did find an increased for hospitalization for heart failure after saxagliptin use. A previous FDA bulletin…Read the article

Hunter Shkolnik: Plaintiffs’ Executive Committee

December 8, 2016

We are proud to announce that Partner Hunter J. Shkolnik has been named as a Plaintiffs’ Executive Committee Member in the Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (Case Number: 3:16-md-02738-FLW-LHG)  by United Stated District Judge Freda L. Wolfson of the United States District Court of New Jersey. The…Read the article

Important World Trade Center Litigation Update

September 28, 2016

Our office has important information to convey to you. As you know our attorneys have successfully represented you in the United States District Court for your WTC injury, obtaining over $800 million in settlements for work place injuries. Now we believe we will have an additional avenue to get you even greater compensation. On Friday, President…Read the article